Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabiola De Marchi

Showing results (81-90 of 120) with videos related to

Pageof 12
Sort By:
Biomedicines|October 28, 2023
Overlapping Neuroimmune Mechanisms and Therapeutic Targets in Neurodegenerative DisordersFabiola De Marchi, Ivana Munitic, Lea Vidatic, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 3, 2025
Another brick in our knowledge of ALS causes: a population-based study of residential clusteringStefano Callegaro, Umberto Manera, Antonio Canosa, et al.
International Journal of Molecular Sciences|October 13, 2021
<i>C9ORF72</i> Repeat Expansion Affects the Proteome of Primary Skin Fibroblasts in ALSMarta Lualdi, Adeena Shafique, Edoardo Pedrini, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 25, 2019
Regional spreading of symptoms at diagnosis as a prognostic marker in amyotrophic lateral sclerosis: a population-based studyUmberto Manera, Andrea Calvo, Margherita Daviddi, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 11, 2022
Respiratory support in a population-based ALS cohort: demographic, timing and survival determinantsAdriano Chio, Cristina Moglia, Antonio Canosa, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|August 6, 2021
Tailoring patients' enrollment in ALS clinical trials: the effect of disease duration and vital capacity cutoffsMaria Claudia Torrieri, Umberto Manera, Gabriele Mora, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 27, 2021
Patient reported outcomes in ALS: characteristics of the self-entry ALS Functional Rating Scale-revised and the Activities-specific Balance Confidence ScaleSheena Chew, Katherine M Burke, Ella Collins, et al.
Aging Clinical and Experimental Research|September 2, 2022
The prevention of falls in patients with Parkinson's disease with in-home monitoring using a wearable system: a pilot study protocolDaiana Campani, Enrico De Luca, Erika Bassi, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|November 11, 2022
Exposure to electromagnetic fields does not modify neither the age of onset nor the disease progression in ALS patientsRosario Vasta, Stefano Callegaro, Maurizio Grassano, et al.
Brain : a Journal of Neurology|October 23, 2025
Profiling cognition and brain metabolism in amyotrophic lateral sclerosis and frontotemporal dementiaFabiola De Marchi, Andrea Baj, Federico Menegon, et al.
Pageof 12

Showing results (81-90 of 120) with videos related to

Sort By:
Pageof 12
Biomedicines|October 28, 2023
Overlapping Neuroimmune Mechanisms and Therapeutic Targets in Neurodegenerative DisordersFabiola De Marchi, Ivana Munitic, Lea Vidatic, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 3, 2025
Another brick in our knowledge of ALS causes: a population-based study of residential clusteringStefano Callegaro, Umberto Manera, Antonio Canosa, et al.
International Journal of Molecular Sciences|October 13, 2021
<i>C9ORF72</i> Repeat Expansion Affects the Proteome of Primary Skin Fibroblasts in ALSMarta Lualdi, Adeena Shafique, Edoardo Pedrini, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 25, 2019
Regional spreading of symptoms at diagnosis as a prognostic marker in amyotrophic lateral sclerosis: a population-based studyUmberto Manera, Andrea Calvo, Margherita Daviddi, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 11, 2022
Respiratory support in a population-based ALS cohort: demographic, timing and survival determinantsAdriano Chio, Cristina Moglia, Antonio Canosa, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|August 6, 2021
Tailoring patients' enrollment in ALS clinical trials: the effect of disease duration and vital capacity cutoffsMaria Claudia Torrieri, Umberto Manera, Gabriele Mora, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 27, 2021
Patient reported outcomes in ALS: characteristics of the self-entry ALS Functional Rating Scale-revised and the Activities-specific Balance Confidence ScaleSheena Chew, Katherine M Burke, Ella Collins, et al.
Aging Clinical and Experimental Research|September 2, 2022
The prevention of falls in patients with Parkinson's disease with in-home monitoring using a wearable system: a pilot study protocolDaiana Campani, Enrico De Luca, Erika Bassi, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|November 11, 2022
Exposure to electromagnetic fields does not modify neither the age of onset nor the disease progression in ALS patientsRosario Vasta, Stefano Callegaro, Maurizio Grassano, et al.
Brain : a Journal of Neurology|October 23, 2025
Profiling cognition and brain metabolism in amyotrophic lateral sclerosis and frontotemporal dementiaFabiola De Marchi, Andrea Baj, Federico Menegon, et al.
Pageof 12